Therapeutic and diagnostic applications of dendrimers for cancer treatment

被引:418
作者
Wolinsky, Jesse B. [1 ]
Grinstaff, Mark W. [1 ]
机构
[1] Boston Univ, Dept Biomed Engn & Chem, Boston, MA 02215 USA
关键词
dendrimer; local therapy; nanoparticle; cancer treatment; drug-conjugates; drug delivery;
D O I
10.1016/j.addr.2008.02.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dendrimers are prepared with a level of control not attainable with most linear polymers, leading to nearly monodisperse, globular macromolecules with a large number of peripheral groups. As a consequence, dendrimers are an ideal delivery vehicle candidate for explicit study of the effects of polymer size, charge, composition, and architecture on biologically relevant properties such as lipid bilayer interactions, cytotoxicity, internalization, blood plasma retention time, biodistribution, and tumor uptake. Over the last several years, substantial progress has been made towards the use of dendrimers for therapeutic and diagnostic purposes for the treatment of cancer, including advances in the delivery of anti-neoplastic and contrast agents, neutron capture therapy, photodynamic therapy, and photothermal therapy. The focus of this review is on dendrimer developments from the last four years for oncological applications, with emphasis on distinct architectures and the biological responses these structures elicit. (c) 2008 Published by Elsevier B.V.
引用
收藏
页码:1037 / 1055
页数:19
相关论文
共 113 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   Synthesis of novel polydiamidopropanoate dendrimer PNA-peptide chimeras for non-invasive magnetic resonance imaging of cancer [J].
Amirkhanov, NV ;
Wickstrom, E .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7) :423-426
[3]   Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature [J].
Backer, MV ;
Gaynutdinov, TI ;
Patel, V ;
Bandyopadhyaya, AK ;
Thirumamagal, BTS ;
Tjarks, W ;
Barth, RF ;
Claffey, K ;
Backer, JM .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (09) :1423-1429
[4]  
BAKER JR, 2000, Patent No. 6471968
[5]   Boron neutron capture therapy of cancer: Current status and future prospects [J].
Barth, RF ;
Coderre, JA ;
Vicente, MGH ;
Blue, TE .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :3987-4002
[6]   BORONATED STARBURST DENDRIMER MONOCLONAL-ANTIBODY IMMUNOCONJUGATES - EVALUATION AS A POTENTIAL DELIVERY SYSTEM FOR NEUTRON-CAPTURE THERAPY [J].
BARTH, RF ;
ADAMS, DM ;
SOLOWAY, AH ;
ALAM, F ;
DARBY, MV .
BIOCONJUGATE CHEMISTRY, 1994, 5 (01) :58-66
[7]   Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy [J].
Battah, SH ;
Chee, CE ;
Nakanishi, H ;
Gerscher, S ;
MacRobert, AJ ;
Edwards, C .
BIOCONJUGATE CHEMISTRY, 2001, 12 (06) :980-988
[8]   Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates [J].
Battah, Sinan ;
Balaratnam, Sherina ;
Casas, Adriana ;
O'Neill, Sophie ;
Edwards, Christine ;
Batlle, Alcira ;
Dobbin, Paul ;
MacRobert, Alexander J. .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (03) :876-885
[9]   Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: An in vitro study [J].
Battah, Sinan ;
O'Neill, Sophie ;
Edwards, Christine ;
Balaratnam, Sherina ;
Dobbin, Paul ;
MacRobert, Alexander J. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (08) :1382-1392
[10]   Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body [J].
Bourne, MW ;
Margerun, L ;
Hylton, N ;
Campion, B ;
Lai, JJ ;
Derugin, N ;
Higgins, CB .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1996, 6 (02) :305-310